Taken together, these results suggested that a reciprocal regulatory network among Cobll1b, PACSIN2, and SH3BP1 controls embryonic hematopoiesis in vertebrates using the same mechanism that regulates nilotinib resistance in CML. The gene discussed is PACSIN2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.